AI For Pharma Growth

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry.   Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and identity theft exploiting medical data breaches. G...

In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience.   SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare professional profiles globally. The discussion pro...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers.   They talk about how generative AI is revolutionising digital marketing and how it can be used for tasks like content creati...

In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm.   He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insights on recent advancements in machine learning an...

In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfeiting. He also explores how patient data on the blo...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu.   They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets.    They exp...

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Piet Buyck, CEO and founder of Garvis AI.   He talks about how the company's AI system provides significantly more accurate demand forecasting for pharmaceutical companies. Piet explains that Garvis AI leverages different data sources and AI techniques to separately forecast demand for various elements, reducing errors by up to 3...

Dr. Andree Bates interviewed Alexander De Ridder, co-founder and CTO of SmythOS, to discuss how their AI agent platform can help pharmaceutical companies scale up their businesses.   Alexander explained that SmythOS allows users to orchestrate intelligent agents that can automate workflows, analyse complex datasets, and augment human work. The agents can collaborate to complete tasks like research...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Saikiran Chandha, founder of SciSpace.   Saikiran discusses how SciSpace uses AI to help researchers save time on literature reviews and writing. SciSpace has developed tools using large language models to summarise papers, generate citations, and paraphrase text while maintaining the desired tone. Saikiran explains how research...

In this episode of AI For Pharma Growth, Dr Andree Bates talks about the state of AI in biopharma, with a specific focus on how it is being applied across the value chain from research and development to business development, licensing, and clinical trials.   She discusses how AI can help accelerate drug discovery by analysing vast amounts of data, generate new drug candidates through machine lear...

In this episode of AI For Pharma Growth, Dr Andree Bates interviews Alice Yu and Mena Abdelsayed, co-founders of OncoCardia.   They discuss how their company uses artificial intelligence and stem cell technology to redesign drugs to be safer and more effective. They aim to reduce the time it takes to develop new drugs from almost a decade to just days or weeks.   OncoCardia leverages AI to predict...

In this episode of AI For Pharma Growth Dr Andree Bates is joined by Mark Benthin, Founder, CEO and Executive Chairman of ViiHealth to discuss how AI can be used to quickly engage HCPs and patients through personalising interactions with marketing content.   Mark discusses ViiHealth's use of generative AI to create personalised videos for physicians and patients using just one hour of recorded con...

In this episode of AI For Pharma Growth, host Dr. Andree Bates is joined by guest Dylan Reid, a Legislative Associate focused on health policy.   Dylan discusses the current state of AI healthcare policy across various US government organisations. He outlines the FDA approval process, initiatives and committees aimed at balancing innovation and oversight. Additionally, Dylan shares his views on us...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Mike Kalfus from Graphene AI.   Mike discusses his background in data-driven marketing and how he came to work at Graphene AI. He explains how Graphene AI uses natural language processing and machine learning to analyse conversations from a variety of data sources to provide pharmaceutical companies actionable insights. Mike det...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Phil Gooch, Founder of Scholarcy.   They discuss how pharma can use AI to create accurate summaries of scientific documents to help medical professionals save time when reviewing literature. Phil describes how he developed the idea for Scholarcy after struggling himself with reviewing many research papers as a PhD student. He ex...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jennifer Bittinger, President of Narrativa.   They discuss Narrativa's use of artificial intelligence to automate the writing of clinical study reports and safety reports. Jennifer explains how she joined the company to help expand their AI automation capabilities in North America.   She gives a case study of how Narrativa helpe...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Max Dordevic, Co-Founder & CEO at NeuroX1.   NeuroX1 is a company that utilises AI to identify and treat neurological diseases that affect millions of people every year. Max discusses how NeuroX1 brings their novel approach to the industry by working diligently to bring viable drug candidates into clinical trials sooner and rein...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Richard Graves, Chief Commercial Officer & Co-founder at Sorcero, to discuss how AI can be used to generate strategic literature reviews accurately and reduce costs for medical affairs teams.   Richard discusses his background in data science and climate science and how his father's cancer diagnosis led him to co-found Sorcero....

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Maddie Bell co-founder & CEO, Scheduler. AI.   Scheduler. AI's AI-powered virtual assistant helps schedule meetings effortlessly. Maddie discusses the background of starting Scheduling. AI, how long it took to develop the first version, challenges faced with cultural biases, and future plans to transform enterprises by giving em...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Adam Kingl to discuss the future of leadership and innovation in pharma. While new technologies are creating medical breakthroughs, they also threaten major revenue decreases for pharma companies. Adam shares how assessing assumptions around customers, offerings, and how value is delivered can spark business model innovation. He...

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jack Bowen, Founder of CoLoop about how to use artificial intelligence to speed up research and analysis for the pharmaceutical industry.   Jack details how CoLoop addresses the problem of time-consuming qualitative data analysis. He explains how CoLoop analyses transcripts and interviews to uncover themes in 70% less time while...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Sidi Lemine, Founder & CEO of Jade Kite, to discuss how AI can be leveraged to analyse qualitative market research more efficiently.   He shares how Jade Kite uses techniques like text analysis and emotion recognition to reduce timelines for qualitative projects from months to just days. He also describes their predictive swarm...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Somer Baburek, CEO & Co-Founder of Hera Biotech.   They discuss how Hera Biotech is developing an artificial intelligence-based diagnostic tool for endometriosis using single-cell analysis of gene expression in endometrial cells. This non-invasive approach could help the millions of women suffering from the disease receive an ea...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr. Guido Axmann, a personal longevity physician and Chief Medical Officer for FOLK.   They discuss how AI and longevity science are converging to advance personalized healthcare and optimization. Topics covered include the hallmarks of ageing, genetic and lifestyle factors, using data and AI for precision medicine, and Dr Axman...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Charles Gellman, CEO of HiDO Health to discuss how HiDO is using AI and automated medication dispensing to improve patient adherence and outcomes.   Charles discusses how his own medical error experience motivated him to start HiDO and ensure patients get the right medications at the right time. He explains how HiDO's device wor...